We advance and expedite the development of rare cardiovascular disease drugs by offering state-of-the-art solutions and services to innovators globally. Our services encompass comprehensive preclinical support for rare cardiovascular diseases, including diagnostic, therapeutic, and disease model development services. We offer customized drug development solutions for rare cardiovascular disease research across different categories.